Complement activation by the amyloid proteins Aβ peptide and β2-microglobulin

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Thioflavine T interaction with synthetic Alzheimer's disease β ‐amyloid peptides: Detection of amyloid aggregation in solution

LeVine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,284

The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease

Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T

Naiki, H., Higuchi, K., Hosokawa, M., & Takeda, T. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90046-8 · Cited by 1,240

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014

Complement activation by beta-amyloid in Alzheimer disease.

Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817

Isolation and Properties of a Low Molecular Weight β2-Globulin Occurring in Human Biological Fluids

Berggård, I., & Bearn, A. G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93284-9 · Cited by 740

The characterization of soluble amyloid prepared in water

Pras, M., Zucker‐Franklin, D., Rimon, A., & Franklin, E. C. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105784 · Cited by 643

Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study

Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454

Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis

Tennent, G. A., Lovat, L. B., & Pepys, M. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4299 · Cited by 438

beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.

Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330

Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.

Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299

Complement activation in amyloid plaques in Alzheimer’s dementia

Eikelenboom, P., Hack, C. E., Rozemüller, A. J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288

Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide

Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255

Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration

Lue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246

Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Coria, F., Castaño, E., Prelli, F. C., Larrondo-Lillo, M., van Duinen, S. G., Shelanski, M. L., & Frangione, B. (1988) · PubMed · Cited by 245

Sulfated glycosaminoglycans: a common constituent of all amyloids?

Snow, A. D., Willmer, J., & Kisilevsky, R. (1987) · PubMed · Cited by 215

Cross-β protein structures. I. Insulin fibrils

Burke, M. J., & Rougvie, M. A. (1972) · Biochemistry · doi:10.1021/bi00763a008 · Cited by 149

BIOLOGY OF SERUM AMYLOID P COMPONENT*

Pepys, M. B., Baltz, M. L., de Beer, F. C., Dyck, R. F., Holford, S., BREATHNACH, S. M., Black, M. M., Tribe, C. R., Evans, D. J., & Feinstein, A. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22144.x · Cited by 142

Beta-2-Microglobulin-Associated Amyloidosis

Floege, J., & Ehlerding, G. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188801 · Cited by 134

Immunodetection of the amyloid P component in Alzheimer's disease

Duong, T., Pommier, E. C., & Scheibel, A. B. (1989) · Acta Neuropathologica · doi:10.1007/bf00688180 · Cited by 111

Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide

Webster, S. D., Bradt, B. M., Rogers, J., & Cooper, N. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010388.x · Cited by 103

Reactions of the Immune System in Chronic Degenerative Neurological Diseases

McGeer, P. L., McGeer, E. G., Kawamata, T., Yamada, T., & Akiyama, H. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032479 · Cited by 86

Parti Nomenclature of amyloid fibril proteins: Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9,1998

Westermark, P., Araki, S., Benson, M. D., Cohen, A. S., Frangione, B., Masters, C. L., Saraiva, M. J., Sipe, J. D., Husby, G., Kyle, R. A., et al. (1999) · Amyloid · doi:10.3109/13506129908993290 · Cited by 66

β2-Microglobulin, Different Fragments and Polymers thereof in Synovial Amyloid in Long-Term Hemodialysis

LINKE, R. P., Hampl, H., BARTEL-SCHWARZE, S., & Eulitz, M. (1987) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1987.368.1.137 · Cited by 59

SPECIFIC CHEMICAL DISSOCIATION OF FIBRILLAR AND NON-FIBRILLAR COMPONENTS OF AMYLOID DEPOSITS

Hind, C. R. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90544-0 · Cited by 57

Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro

McGeer, P. L., Walker, D. G., Pitas, R. E., Mahley, R. W., & McGeer, E. G. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01324-8 · Cited by 43

Purification, Subunit Characterization and Ultrastructure of Three Soluble Bovine Lectins: Conglutinin, Mannose‐Binding Protein and the Pentraxin Serum Amyloid P‐Component

Andersen, O., Friis, P., Nielsen, E. H., Vilsgaard, K., Leslie, R. G. Q., & Svehag, S. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb02949.x · Cited by 24

Roles of Immunoglobulins in Amyloidogenesis in Cutaneous Nodular Amyloidosis

Ito, K., Hashimoto, K., Kambe, N., & Van, S. L. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12471778 · Cited by 22

Molecular variants of β2-microglobulin in renal insufficiency

Vincent, C., Dennoroy, L., & Révillard, J. P. (1994) · Biochemical Journal · doi:10.1042/bj2980181 · Cited by 20

Immunofluorescence Findings in Human Renal Amyloidosis

Jerath, R. S., Valenzuela, R., Guerrero, I. A. C., Deodhar, S. D., & Vidt, D. B. (1980) · American Journal of Clinical Pathology · doi:10.1093/ajcp/74.5.630 · Cited by 18

Cardiovascular abnormalities in the marfanoid hypermobility syndrome

Cotton, D. J., & Brandt, K. D. (1976) · Arthritis & Rheumatism · doi:10.1002/1529-0131(197607/08)19:4 · Cited by 16

Immunofluorescence study of “Non-idiopathic” renal amyloidosis

Orfila, C., Rakotoarivony, J., Segonds, A., & Suc, J. M. (1983) · Human Pathology · doi:10.1016/s0046-8177(83)80123-3 · Cited by 13

Monomeric and dimeric 2-microglobulin may be extracted from amyloid deposits in vitro

Garcia-Garcia, M., Gouin, A., Mourad, G., & Argilés, À. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.6.1192 · Cited by 11

Synovial inflammatory cells captured131I-β2-microglobulin in patients with dialysis related amyloidosis

Kazama, J. J., Arakawa, M., & Gejyo, F. (1998) · Amyloid · doi:10.3109/13506129809007286 · Cited by 8

Separation of Amyloid Proteins by Size-Exclusion Chromatography in Aqueous Organic Mobile Phase

Kaplan, B., & Pras, M. (1992) · Journal of Liquid Chromatography · doi:10.1080/10826079208017196 · Cited by 7

C1Q Complexes with Beta-2-Microglobulin and Amyloid P-Component in Sera of Patients with Dialysis-Associated Amyloidosis

Hasegawa, M., Kawashima, S., Shikano, M., Kojima, K., Yanai, T., Hassegawa, H., Tomita, M., Murakami, K., Kawamura, N., & Katsumata, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188506 · Cited by 5

Isoforms of Murine and Human Serum Amyloid P Component

Nybo, M., Hackler, R., Kold, B., Nielsen, E. H., Steinmetz, A., & Svehag, S. (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00404.x · Cited by 3

Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation

Sullivan, K. D., Evans, D., Pandey, A., Hraha, T. H., Smith, K. P., Markham, N., Rachubinski, A. L., Wolter-Warmerdam, K., Hickey, F., Espinosa, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13858-3 · Cited by 228

Plaque complement activation and cognitive loss in Alzheimer's disease

Loeffler, D. A., Camp, D. M., & Bennett, D. A. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-9 · Cited by 68

β2-microglobulin: from physiology to amyloidosis

Heegaard, N. (2009) · Amyloid: Journal of Protein Folding Disorders · doi:10.1080/13506120903151775 · Cited by 60

Dialysis‐Related Amyloidosis: Pathogenesis Focusing on AGE Modification

Niwa, T. (2001) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2001.00031.x · Cited by 35

Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies

Horváth, A., Andersen, I., Junker, K., Fogh-Schultz, B. L., Nielsen, E. H., Gizurarson, S. S., Andersen, O., Kármán, J., Rajnavölgyi, É., Erdei, A., et al. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00158-9 · Cited by 34

The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation

Kułak, K. B., Westermark, G. T., Papac-Miličević, N., Renström, E., Blom, A. M., & King, B. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4286-3 · Cited by 24

Complexes of Serum Amyloid P Component and DNA in Serum from Healthy Individuals and Systemic Lupus Erythematosus Patients

Sørensen, I. J., Nielsen, E. H., Schrøder, L., Voss, A., Horváth, L., & Svehag, S.-E. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1026478914129 · Cited by 16

Molecular heterogeneity of amyloid β2-microglobulin and modification with advanced glycation end products

Mironova, R., & Niwa, T. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00139-6 · Cited by 9

Potential Intervention by Vaccinia Virus Complement Control Protein of the Signals Contributing to the Progression of Central Nervous System Injury to Alzheimer's Disease

Kotwal, G., Lahiri, D., & Hicks, R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04659.x · Cited by 11

Alzheimer disease and neuroinflammation in Down syndrome

Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00014-4

Gene-dosage imbalance due to trisomic HSA21 and genotype–phenotype association in Down syndrome

Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00005-3

Development of specific phenotypes and genetic consequences in Down syndrome

Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00002-8 · Cited by 1

Association of nonfribrillar amyloid oligomers with drusen of aging and age-related macular degeneration

Luibl, V. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.5701

Complement activation by cross-linked truncated and chimeric full-length β-amyloid

Cribbs, D. H., Velázquez, P., Soreghan, B. A., Glabe, C. G., & Tenner, A. J. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00009 · Cited by 26

Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide

Webster, S. D., Bradt, B. M., Rogers, J., & Cooper, N. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010388.x · Cited by 103

Complement System Activation by Amyloid Aggregates of Aβ(1-40) and Aβ(1-42) Peptides: Facts and Hypotheses

Yakupova, E. I., Bobyleva, L. G., Vikhlyantsev, I. M., & Bobylev, A. G. (2020) · BIOPHYSICS · doi:10.1134/s000635092001025x · Cited by 3

Complement activation by the amyloid proteins A-beta-peptide and beta2-microglobulin:Amyloid

Nybo, M., Nielsen, E. H., & Svehag, S. (1999) · University of Southern Denmark Research Portal (University of Southern Denmark)

Alzheimer's β-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner

Bergamaschini, L. C., Canziani, S., Bottasso, B., Cugno, M., Braidotti, P., & Agostoni, A. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00835.x · Cited by 39